US Stock MarketDetailed Quotes

FRTX Fresh Tracks Therapeutics

Watchlist
  • 0.905
  • +0.005+0.50%
Close Mar 28 16:00 ET
5.40MMarket Cap-853P/E (TTM)

About Fresh Tracks Therapeutics Company

Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.

Company Profile

SymbolFRTX
Company NameFresh Tracks Therapeutics
Listing Date03/09/1993
Founded2009
CEOMr. Albert N. Marchio
MarketPink Market
Employees4
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address5777 Central Avenue,Suite 102
CityBoulder
ProvinceColorado
CountryUnited States of America
Zip Code80301
Phone1-720-505-4755

Company Executives

  • Name
  • Position
  • Salary
  • Albert N. Marchio
  • Chairman of the Board, Chief Executive Officer, Chief Financial Officer, and Secretary
  • --
  • Deepak Chadha
  • Chief Research and Development Officer and Chief Operating Officer
  • 713.77K
  • David R. McAvoy
  • General Counsel and Chief Compliance Officer
  • --
  • Aaron Fox-Collis
  • Vice President of Finance and Chief Accounting Officer
  • --
  • Dr. Mammen P. Mammen, Jr,M.D.
  • Senior Vice President, Clinical Development
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg